期刊文献+

多孔CPC材料复合转染VEGF的骨髓间充质干细胞修复大鼠颅骨缺损的实验研究

Experimental Study of Construction of Tissue Engineered Bone by Porous CPC with Bone Mesenchymal Stem Cells Transfected with VEGF Gene for Repair of Rat Skull Defect
下载PDF
导出
摘要 为研究转染血管内皮生长因子(VEGF)基因的骨髓间充质干细胞(BMSCs)复合多孔CPC构建的组织工程化骨对骨缺损的修复作用,用脂质体介导质粒pIRES2-EGFP/VEGF165转染大鼠BMSCs,与多孔CPC复合体外构建组织工程化骨,植入大鼠颅骨缺损模型,未转染VEGF165的组织工程化骨作对照。分别在4周、12周取材,以组织学组织形态学分析骨缺损修复情况.比较两组的骨形成差异。结果转染VEGF组骨缺损的修复效果明显好于未转染组。组织形态计量学分析显示,4周时,转染组材料内新生骨面积为31.9%,未转染组为19.7%。12周时,转染组材料内新生骨面积为75.9%,未转染组仅为49.7%。差异具有统计学意义(P<0.000 1)。转染组的骨形成速率明显快于未转染组,两者分别为分别为6.18±1.62μm/d和3.56±0.93μm/d。说明VEGF转染细胞组较对照组血供加强,骨缺损修复加速。 To study the repair effect of porous CPC with bone mesenchymal stem cells transfected with VEGF gene on bone defect,a eukaryotic expression vector pIRES2-EGFP/VEGF165 was transfected by liposome DoTAP into rat BMSCs,then seeded into porous CPC and constructed tissue engineered bone,which repaired rat skull defect.The porous CPC with BMSCs is control group.The follow up times were 4,12 weeks.Histological study were performed to observe the skull defect healing.It is results of that better ossification was observed in the transfected with VEGF experimental group compared to the single BMSCs with collagen control group including more newly formed bone tissue and higher rate of bone formation.The area of new bone formed(%) in the transfected with VEGF experimental group and the single BMSCs with collagen control group were 31.9% and 19.7% at 4 weeks respectively,and 75.9%,49.7% at 12 weeks.The rate of bone formation on the transfected with VEGF experimental group and the single BMSCs with collagen control group were(6.18±1.62) μm/d and(3.56±0.93) μm/d respectively.It is conclused that transfer of gene encoding VEGF increases repair of bone defect and provides rich blood supply for repairing.
出处 《科学技术与工程》 2011年第16期3622-3626,3631,共6页 Science Technology and Engineering
关键词 骨缺损 骨组织工程 血管内皮生长因子 骨髓间充质干细胞 基因转染 bone defect bone issue engineering vascular endothelial growth factor bone mesenchymal stem cells Gene transfection
  • 相关文献

参考文献8

  • 1Weiland A J. Vascularized bone autogrfts: experience with 41 cases. Clin Orthop,1983 ; (174) :87-89. 被引量:1
  • 2易甫,吕安林,贾国良,张荣庆.血管内皮细胞生长因子真核表达质粒的构建及其在心肌细胞中的表达[J].心脏杂志,2003,15(3):218-222. 被引量:5
  • 3Khademhosseini A, Langer R, Borenstein J, et al. Microscale tech- nologies for tissue engineering and biology. Proceedings of the Nation- al Academy of Sciences of the United States of America 2006 ; 103 : 2480-2487. 被引量:1
  • 4Folkman J, Shing Y. Angiogenesis. J Biol Chem, 1992,267 ( 16 ) : 10931-10934. 被引量:1
  • 5Szuba A, Skobe M, Karkkainen M J, et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J, 2002;16(14) : 1985-1987. 被引量:1
  • 6Schuh A, Breuer S, A1 Dashti R, et al. Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther, 2005 ; 10 ( 1 ) : 55 --66. 被引量:1
  • 7Ishikawa M, Fjii M, Iuchi M, et al. Effect of intrahepatic omental implantation on angiogenesis in rat liver with hepatic artery ligation. Clin Exp Med, 2001 ;1 ( 1 ) :27-33. 被引量:1
  • 8裴国献,金丹.骨组织工程学种子细胞研究进展[J].中华创伤骨科杂志,2003,5(1):55-58. 被引量:27

二级参考文献32

  • 1Folkman J,Shing Y. Angiogenesis[J]. J Biol Chem, 1992,267(16) :10931--10934. 被引量:1
  • 2Neufeld G,Cohen T,Stela G,et al. Vascular endothelial growth factor (VEGF) and its receptors [J]. FASEB J, 1999,13 (1): 9--22. 被引量:1
  • 3Mack CA, Patel SR, Schwarz EA,et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular enthelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J]. J Thorac Cardiovasc Surg, 1998,115 ( 1 ): 168--177. 被引量:1
  • 4Tio RA ,Tkehuchava T,Scheuermann TH ,et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardial[J]. Hum Gene Ther,1999,10(18) ,2953--2960. 被引量:1
  • 5Schwarz ER, Speskman MT, Patterson M,et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation[J]. J Am Coll Cardiol, 2000,35( 5):1323--1330. 被引量:1
  • 6Losordo DW,Vale PR,Symes JF,et al. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia[J]. Circulation,1998, 98(25):2800--2804. 被引量:1
  • 7Rosengart TK, Lee LY,Patel SR ,et al. Six-- month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA[J]. Ann Surg,1999,230(4):466--472. 被引量:1
  • 8Symes JF,Losordo DW,Vale PR,et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J]. Ann Thorac surg, 1999,68 (3): 830-- 837. 被引量:1
  • 9Neufeld G,Cohen T,Gitay-Goren H,et al. Similarities and difference between the vascular endothelial growth factor(VEGF)splice variants cancer[J]. Cancer Metastasis Rev, 1996, 15(2) :153--158. 被引量:1
  • 10Vacanti CA;Upton J.Tissue-engineered morphogenesis of cartilage and bone by means of cell transplantation using synthetic biodegradable polymer matrices,1994. 被引量:2

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部